- THIRD QUARTER REVENUE OF $134.4
MILLION, UP 3% SEQUENTIALLY AND OVER 7%
YEAR-OVER-YEAR
- THIRD QUARTER OPERATING INCOME OF $19.8 MILLION; EX-ITEMS, $18.2 MILLION, UP 11% SEQUENTIALLY AND 14%
YEAR-OVER-YEAR
- THIRD QUARTER OPERATING MARGINS, EX-ITEMS, OF 14% UP 100 BPS
SEQUENTIALLY
- THIRD QUARTER GAAP EPS OF $0.25; EX-ITEMS, $0.25, UP 14% SEQUENTIALLY AND
YEAR-OVER-YEAR
- THIRD QUARTER FREE CASH FLOW OF $10.4
MILLION
- NET DEBT REDUCED BY $11.8
MILLION; DEBT LEVERAGE RATIO REDUCED TO 1.47
- COMPANY ANNOUNCES Q4 2024 QUARTERLY DIVIDEND
HOUSTON, Oct. 23,
2024 /PRNewswire/ -- Core Laboratories Inc. (NYSE:
"CLB") ("Core", "Core Lab", or the "Company") reported third
quarter 2024 revenue of $134,400,000.
Core's operating income was $19,800,000, with diluted earnings per share
("EPS") of $0.25, all in accordance
with U.S. generally accepted accounting principles ("GAAP").
Operating income, ex-items, a non-GAAP financial measure, was
$18,200,000, yielding operating
margins of 14%, up 100 basis points sequentially, and EPS,
ex-items, of $0.25. During the third
quarter of 2024, the Company recorded an adjustment of $1,400,000 to stock compensation expense for
certain performance share awards which are no longer expected to
vest. A full reconciliation of non-GAAP financial measures is
included in the attached financial tables.
Core's CEO, Larry Bruno stated,
"In the third quarter of 2024, Core Lab delivered solid sequential
improvements in revenue, operating income, operating margins,
incremental margins and earnings per share. Demand for our
Reservoir Description services continued to grow across our
international laboratory network despite headwinds from on-going
geopolitical conflicts. In Production Enhancement, revenue
increased sequentially, driven by higher international product
sales. However, these improvements were somewhat offset by
hurricane-related delays in diagnostic service revenue tied to
suspended well operations in the Gulf of Mexico. Following
positive meetings with Middle East
operators in the second quarter of 2024, personal face-to-face
meetings with Asia-Pacific
operators during the third quarter reinforced growth opportunities
for both of Core's operating segments. Collectively, these client
meetings support our perspective for a multi-year cycle of expanded
project activity. At the end of the third quarter, the Company
achieved its longstanding goal of reducing our debt leverage ratio
to below 1.50. The leverage ratio is now at its lowest level in
over six years. Core remains focused on executing its strategic
business initiatives while also reducing our debt leverage ratio,
as the Company evaluates various opportunities to increase
shareholder value."
Reservoir Description
Reservoir Description operations are closely correlated with
trends in international and offshore activity levels, with
approximately 80% of revenue sourced from projects originating
outside the U.S. Revenue in the third quarter of 2024 was
$88,800,000, up 3% sequentially and
over 4% from last year. Operating income on a GAAP basis was
$16,500,000, while operating income,
ex-items, was $15,400,000, yielding
operating margins of over 17%, a sequential improvement of 370
basis points. The segment's financial performance in the third
quarter reflects growing demand for reservoir rock and fluid
analysis across the Company's global operations. This growth
occurred despite negative impacts from both on-going geopolitical
conflicts, as well as disruption of work in the Gulf of Mexico due to weather events.
Core Lab continues to expand its engagement in Carbon Capture
and Sequestration ("CCS") projects, leveraging its expertise in
reservoir characterization. In addition to Core's multi-company
joint industry project that is being conducted in conjunction with
Dr. Birol Dindoruk of the University of
Houston, during the third quarter of 2024, the Company
secured multiple contracts to evaluate CCS sites across the Gulf
Coast region and other parts of the
United States. Employing its proprietary laboratory
reservoir characterization technologies, Core Lab is performing
detailed petrophysical, geological and geochemical analyses, along
with fluid flow experiments, formation damage assessments, and
geomechanical testing. Core Lab's technologies are critical for
evaluating the long-term viability of potential CO2
injection sites.
Also, during the third quarter of 2024, engagement on projects
in the Middle East continued to
expand. Kuwait Oil Company ("KOC") selected Core Laboratories to
lead a comprehensive fluid analysis campaign as part of an offshore
exploration program in the Arabian Gulf. The project area is
considered to have high potential for contributing to KOC's
long-term production growth goals. High-quality
pressure-volume-temperature ("PVT") analysis and advanced
analytical chemistry are critical for evaluating reservoir
maturity, volumetric potential, and production characteristics. The
hard data points that Core Lab provides form the backbone of the
reservoir models operators use to make major investment
decisions.
Production Enhancement
Production Enhancement operations, which are focused on complex
completions in unconventional oil and gas reservoirs in the U.S.,
as well as conventional and unconventional projects across the
globe, posted third quarter 2024 revenue of $45,600,000, up 3% sequentially and over 13%
year-over-year. Operating income on a GAAP basis was $3,200,000, while operating income, ex-items, was
$2,600,000, yielding operating
margins of 6%. The sequential financial performance reflects
improvement in international product sales; however, this was
offset by 1) a delay of diagnostic service revenue related to
multiple hurricanes in the Gulf of
Mexico and 2) to a lesser extent, a decline in U.S. land
completion activity.
In the third quarter of 2024, Core Lab's completion diagnostic
technologies were utilized to provide insight into complex
unconventional completions. For several years, operators in
Alberta, Canada have been drilling
and completing open-hole multilateral wells to optimize reservoir
drainage. This wellbore architecture makes it difficult to confirm
oil production from comingled laterals. Recently, an operator used
Core's diagnostic technologies to determine if oil was being
produced from individual laterals. To accomplish this, Core
deployed its proprietary solid Flow Profiler OilTM
technology, which placed a unique oil-activated tracer in each
lateral. During initial production, fluid samples were collected at
the surface and analyzed in the laboratory. The test results
confirmed oil production from each lateral. Subsequently, the
operator asked Core Lab to both confirm oil production from each
lateral, and to identify the source(s) of produced water. The
lab data from water tracers will provide the operator with the
option to shut off boreholes with excessive water-production, thus
reducing disposal costs. Core is currently preparing to deploy a
family of newly developed solid water tracers that will also be
placed in each lateral. By utilizing both oil and water tracers,
the produced fluid samples will help the operator better understand
how individual boreholes are contributing to comingled
production.
In 2023, a national oil company in the Middle East engaged Core's ballistic
engineering team to develop a solution to improve operational
efficiencies and reduce costs in offshore plug and abandonment
("P&A") well operations. Leveraging its expertise in energetics
as an alternative to traditional casing section milling, Core
developed an innovative technology to accelerate P&A
operations. During the third quarter of 2024, the Company's
ballistic engineering design team deployed its patented Pulverizor™
technology. The Pulverizor™ technology: 1) rubbilizes the cement,
2) generates a significant level of cement debonding with the
target casing interval, and 3) allows the casing to be pulled to
the surface without having to wash the annulus. Field trials
successfully demonstrated that PulverizorTM reduced the
amount of rig overpull required to retrieve casing without having
to conduct the wash operation. Pulverizor™ not only contributes to
the safety of offshore well abandonment, but also aligns with
increasing global demand for cost-effective solutions in complex
P&A applications. Core Lab is presenting this new technology as
a co-author and co-presenter at ADIPEC in November of this
year.
Liquidity, Free Cash Flow and Dividend
Core continues to focus on maximizing free cash flow ("FCF"), a
non-GAAP financial measure defined as cash from operations less
capital expenditures. For the third quarter of 2024, cash from
operations was $13,100,000 and
capital expenditures were $2,700,000,
yielding FCF of $10,400,000. The
Company generated $27,100,000 of FCF
for the nine months ended September 30,
2024, a significant improvement from the same period last
year. The year-over-year improvement in FCF generated during 2024
reflects higher profitability, as well as better management of
inventory and working capital.
Core expects to continue generating positive free cash flow in
future quarters. As of September 30, 2024, Core's net debt
(defined as long-term debt less cash and cash equivalents) was
$120,500,000, which was reduced by
$11,800,000 during the quarter. The
Company's leverage ratio (calculated as total net debt divided by
adjusted EBITDA for the last four quarters) was reduced to 1.47 as
of September 30, 2024, which improved
from 1.66 as of June 30, 2024. Core
will remain focused on executing its strategic business initiatives
while also further reducing our debt leverage ratio as the Company
continues to evaluate allocation of capital and other uses of free
cash.
On July 24, 2024, Core's Board of
Directors ("Board") announced a quarterly cash dividend of
$0.01 per share of common stock,
which was paid on August 26, 2024 to
shareholders of record on August 5,
2024.
On October 23, 2024, the Board
approved a cash dividend of $0.01 per
share of common stock payable on November
25, 2024 to shareholders of record on November 4, 2024.
Return On Invested Capital
The Board and the Company's Executive Management continue to
focus on strategies that maximize return on invested capital
("ROIC") and FCF, factors that have high correlation to total
shareholder return. Core's commitment to an asset-light business
model and disciplined capital stewardship promotes capital
efficiency and are designed to produce more predictable and
superior long-term ROIC.
The Board has established an internal metric to demonstrate ROIC
performance relative to the oilfield service companies listed as
Core's Comp Group by Bloomberg, as the Company continues to believe
superior ROIC will result in higher total shareholder return. Using
Bloomberg's formula, the Company's ROIC as of September 30, 2024 was 8.6%.
Industry and Core Lab Outlook and Guidance
Core Lab continues to see a multi-year international recovery
due to underinvestment, increasing focus on energy security and
rising crude-oil demand, all supporting continued activity growth
into 2025. In alignment with this outlook, Core will continue
to execute its strategic plan of investing in technology and
pursuing growth opportunities, while remaining well-engaged on
long-cycle international projects. The IEA, EIA and OPEC+ continue
to forecast growth in crude-oil demand between 1.0 and 1.6 million
barrels per day for 2025, which is in addition to the natural
decline of production from existing fields. As such, continued
investment in the development of onshore and offshore crude-oil
fields will be required to meet the projected growth in demand. In
the near-term, we expect that crude-oil markets will remain
volatile due to global economic and geopolitical risks and
uncertainties.
Consequently, as international project activity continues to
expand, committed long-term upstream projects from the Middle East, South Atlantic Margin, certain
areas of Asia Pacific and
West Africa support year-over-year
growth in demand for Core Lab's services and products. Core
anticipates U.S. land activity to trend lower in the fourth quarter
of 2024, however, return to similar activity levels year-over-year
in 2025. For the near-term, U.S. land activity is currently
negatively influenced by recent E&P consolidations and weak
natural gas prices.
Fourth quarter 2024 guidance for both business segments includes
the impact of client project delays caused by weather events in the
Gulf of Mexico. Core projects
Reservoir Description's fourth quarter 2024 revenue to be flat to
up slightly. Turning to Production Enhancement, the U.S. frac
spread count continues to trend lower. In addition, the Company
anticipates the typical year-end seasonal decline in U.S. onshore
completion activity.
Reservoir Description's fourth quarter 2024 revenue is projected
to range from $87,500,000 to
$90,500,000, with operating income of
$13,400,000 to $14,900,000. Core's Production Enhancement
segment's fourth quarter 2024 revenue is estimated to range from
$41,000,000 to $45,000,000, with operating income of
$1,300,000 to $2,700,000.
The Company's fourth quarter 2024 revenue is projected to range
from $128,500,000 to $135,500,000, with operating income of
$14,800,000 to $17,700,000, yielding operating margins of
approximately 12%. EPS for the fourth quarter of 2024 is expected
to be $0.20 to $0.25.
The Company's fourth quarter 2024 guidance is based on
projections for underlying operations and excludes gains and losses
in foreign exchange. Fourth quarter 2024 guidance also assumes an
effective tax rate of 20%.
Earnings Call Scheduled
The Company has scheduled a conference call to discuss Core's
third quarter 2024 earnings announcement. The call will begin at
7:30 a.m. CDT / 8:30 a.m. EDT on Thursday, October 24,
2024. To listen to the call, please go to Core's website at
www.corelab.com.
Core Laboratories Inc. is a leading provider of proprietary and
patented reservoir description and production enhancement services
and products used to optimize petroleum reservoir performance. The
Company has over 70 offices in more than 50 countries and is
located in every major oil-producing province in the world. This
release, as well as other statements we make, includes
forward-looking statements regarding the Company's future revenue,
profitability, business strategies and developments, demand for the
Company's products and services and for products and services of
the oil and gas industry generally, made in reliance upon the safe
harbor provisions of Federal securities law. The Company's outlook
is subject to various important cautionary factors, including risks
and uncertainties related to the oil and natural gas industry,
business and general economic conditions, including inflationary
pressures, the ability to achieve the benefits of the
redomestication of the parent company from the Netherlands to the United States, international markets,
international political climates, including the Russia-Ukraine and the Middle East geopolitical conflicts, public
health crises, and any related actions taken by businesses and
governments, and other factors as more fully described in the
Company's most recent Forms 10-K, 10-Q and 8-K filed with or
furnished to the U.S. Securities and Exchange Commission. These
important factors could cause the Company's actual results to
differ materially from those described in these forward-looking
statements. Such statements are based on current expectations of
the Company's performance and are subject to a variety of factors,
some of which are not under the control of the Company. Because the
information herein is based solely on data currently available, and
because it is subject to change as a result of changes in
conditions over which the Company has no control or influence, such
forward-looking statements should not be viewed as assurance
regarding the Company's future performance.
The Company undertakes no obligation to publicly update or
revise any forward-looking statement to reflect events or
circumstances that may arise after the date of this press release,
except as required by law.
Visit the Company's website at www.corelab.com. Connect with
Core Lab on Facebook, LinkedIn and YouTube.
CORE LABORATORIES
INC. & SUBSIDIARIES
CONDENSED
CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except
per share data)
(Unaudited)
|
|
|
|
Three Months
Ended
|
|
|
%
Variance
|
|
|
September 30,
2024
|
|
|
June 30,
2024
|
|
|
September 30,
2023
|
|
|
vs.
Q2-24
|
|
vs.
Q3-23
|
REVENUE
|
|
$
|
134,397
|
|
|
$
|
130,577
|
|
|
$
|
125,343
|
|
|
2.9 %
|
|
7.2 %
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
OPERATING
EXPENSES:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Costs of services and
product sales
|
|
|
106,805
|
|
|
|
102,930
|
|
|
|
96,617
|
|
|
3.8 %
|
|
10.5 %
|
General and
administrative expense
|
|
|
8,642
|
|
|
|
10,259
|
|
|
|
9,452
|
|
|
(15.8) %
|
|
(8.6) %
|
Depreciation and
amortization
|
|
|
3,676
|
|
|
|
3,770
|
|
|
|
3,929
|
|
|
(2.5) %
|
|
(6.4) %
|
Other (income) expense,
net
|
|
|
(4,529)
|
|
|
|
(2,390)
|
|
|
|
673
|
|
|
NM
|
|
NM
|
Total operating
expenses
|
|
|
114,594
|
|
|
|
114,569
|
|
|
|
110,671
|
|
|
— %
|
|
3.5 %
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
OPERATING
INCOME
|
|
|
19,803
|
|
|
|
16,008
|
|
|
|
14,672
|
|
|
23.7 %
|
|
35.0 %
|
Interest
expense
|
|
|
3,108
|
|
|
|
3,209
|
|
|
|
3,147
|
|
|
(3.1) %
|
|
(1.2) %
|
Income before income
taxes
|
|
|
16,695
|
|
|
|
12,799
|
|
|
|
11,525
|
|
|
30.4 %
|
|
44.9 %
|
Income tax
expense
|
|
|
4,691
|
|
|
|
3,609
|
|
|
|
2,305
|
|
|
30.0 %
|
|
103.5 %
|
Net income
|
|
|
12,004
|
|
|
|
9,190
|
|
|
|
9,220
|
|
|
30.6 %
|
|
30.2 %
|
Net income (loss)
attributable to non-controlling interest
|
|
|
259
|
|
|
|
158
|
|
|
|
(37)
|
|
|
NM
|
|
NM
|
Net income attributable
to Core Laboratories Inc.
|
|
$
|
11,745
|
|
|
$
|
9,032
|
|
|
$
|
9,257
|
|
|
30.0 %
|
|
26.9 %
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted earnings per
share
|
|
$
|
0.25
|
|
|
$
|
0.19
|
|
|
$
|
0.19
|
|
|
31.6 %
|
|
31.6 %
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted earnings per
share attributable to Core Laboratories Inc.
|
|
$
|
0.25
|
|
|
$
|
0.19
|
|
|
$
|
0.19
|
|
|
31.6 %
|
|
31.6 %
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted weighted
average common shares outstanding
|
|
|
47,820
|
|
|
|
47,743
|
|
|
|
47,604
|
|
|
0.2 %
|
|
0.5 %
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Effective tax
rate
|
|
|
28
|
%
|
|
|
28
|
%
|
|
|
20
|
%
|
|
NM
|
|
NM
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
SEGMENT
INFORMATION:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenue:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reservoir
Description
|
|
$
|
88,840
|
|
|
$
|
86,277
|
|
|
$
|
85,145
|
|
|
3.0 %
|
|
4.3 %
|
Production
Enhancement
|
|
|
45,557
|
|
|
|
44,300
|
|
|
|
40,198
|
|
|
2.8 %
|
|
13.3 %
|
Consolidated
|
|
$
|
134,397
|
|
|
$
|
130,577
|
|
|
$
|
125,343
|
|
|
2.9 %
|
|
7.2 %
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating
income:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reservoir
Description
|
|
$
|
16,487
|
|
|
$
|
11,443
|
|
|
$
|
12,992
|
|
|
44.1 %
|
|
26.9 %
|
Production
Enhancement
|
|
|
3,232
|
|
|
|
4,401
|
|
|
|
1,544
|
|
|
(26.6) %
|
|
109.3 %
|
Corporate and
Other
|
|
|
84
|
|
|
|
164
|
|
|
|
136
|
|
|
NM
|
|
NM
|
Consolidated
|
|
$
|
19,803
|
|
|
$
|
16,008
|
|
|
$
|
14,672
|
|
|
23.7 %
|
|
35.0 %
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
"NM" means not
meaningful
|
|
|
|
|
|
|
|
|
|
|
|
|
|
CORE LABORATORIES
INC. & SUBSIDIARIES
CONDENSED
CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except
per share data)
(Unaudited)
|
|
|
|
Nine Months
Ended
September 30,
|
|
|
%
Variance
|
|
|
2024
|
|
|
2023
|
|
|
|
REVENUE
|
|
$
|
394,611
|
|
|
$
|
381,580
|
|
|
3.4 %
|
|
|
|
|
|
|
|
|
|
OPERATING
EXPENSES:
|
|
|
|
|
|
|
|
|
Costs of services and
product sales
|
|
|
314,323
|
|
|
|
298,440
|
|
|
5.3 %
|
General and
administrative expense
|
|
|
30,690
|
|
|
|
31,594
|
|
|
(2.9) %
|
Depreciation and
amortization
|
|
|
11,289
|
|
|
|
11,910
|
|
|
(5.2) %
|
Other (income) expense,
net
|
|
|
(6,073)
|
|
|
|
(423)
|
|
|
NM
|
Total operating
expenses
|
|
|
350,229
|
|
|
|
341,521
|
|
|
2.5 %
|
|
|
|
|
|
|
|
|
|
OPERATING
INCOME
|
|
|
44,382
|
|
|
|
40,059
|
|
|
10.8 %
|
Interest
expense
|
|
|
9,740
|
|
|
|
9,812
|
|
|
(0.7) %
|
Income before income
taxes
|
|
|
34,642
|
|
|
|
30,247
|
|
|
14.5 %
|
Income tax expense
(benefit)
|
|
|
9,958
|
|
|
|
(4,344)
|
|
|
NM
|
Net income
|
|
|
24,684
|
|
|
|
34,591
|
|
|
(28.6) %
|
Net income attributable
to non-controlling interest
|
|
|
687
|
|
|
|
115
|
|
|
NM
|
Net income attributable
to Core Laboratories Inc.
|
|
$
|
23,997
|
|
|
$
|
34,476
|
|
|
(30.4) %
|
|
|
|
|
|
|
|
|
|
Diluted earnings per
share
|
|
$
|
0.52
|
|
|
$
|
0.73
|
|
|
(28.8) %
|
|
|
|
|
|
|
|
|
|
Diluted earnings per
share attributable to Core Laboratories Inc.
|
|
$
|
0.50
|
|
|
$
|
0.73
|
|
|
(31.5) %
|
|
|
|
|
|
|
|
|
|
Diluted weighted
average common shares outstanding
|
|
|
47,690
|
|
|
|
47,536
|
|
|
0.3 %
|
|
|
|
|
|
|
|
|
|
Effective tax
rate
|
|
|
29
|
%
|
|
|
(14)
|
%
|
|
NM
|
|
|
|
|
|
|
|
|
|
SEGMENT
INFORMATION:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenue:
|
|
|
|
|
|
|
|
|
Reservoir
Description
|
|
$
|
259,353
|
|
|
$
|
248,717
|
|
|
4.3 %
|
Production
Enhancement
|
|
|
135,258
|
|
|
|
132,863
|
|
|
1.8 %
|
Consolidated
|
|
$
|
394,611
|
|
|
$
|
381,580
|
|
|
3.4 %
|
|
|
|
|
|
|
|
|
|
Operating
income:
|
|
|
|
|
|
|
|
|
Reservoir
Description
|
|
$
|
34,823
|
|
|
$
|
28,780
|
|
|
21.0 %
|
Production
Enhancement
|
|
|
9,209
|
|
|
|
10,324
|
|
|
(10.8) %
|
Corporate and
Other
|
|
|
350
|
|
|
|
955
|
|
|
NM
|
Consolidated
|
|
$
|
44,382
|
|
|
$
|
40,059
|
|
|
10.8 %
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
"NM" means not
meaningful
|
|
|
|
|
|
|
|
|
CORE LABORATORIES
INC. & SUBSIDIARIES
CONDENSED
CONSOLIDATED BALANCE SHEETS
(In
thousands)
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
%
Variance
|
ASSETS:
|
|
September 30,
2024
|
|
|
June 30,
2024
|
|
|
December 31,
2023
|
|
|
vs.
Q2-24
|
|
vs.
Q4-23
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash
equivalents
|
|
$
|
21,474
|
|
|
$
|
17,695
|
|
|
$
|
15,120
|
|
|
21.4 %
|
|
42.0 %
|
Accounts receivable,
net
|
|
|
117,591
|
|
|
|
115,644
|
|
|
|
109,352
|
|
|
1.7 %
|
|
7.5 %
|
Inventories
|
|
|
65,490
|
|
|
|
69,898
|
|
|
|
71,702
|
|
|
(6.3) %
|
|
(8.7) %
|
Other current
assets
|
|
|
30,672
|
|
|
|
30,291
|
|
|
|
26,962
|
|
|
1.3 %
|
|
13.8 %
|
Total current
assets
|
|
|
235,227
|
|
|
|
233,528
|
|
|
|
223,136
|
|
|
0.7 %
|
|
5.4 %
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Property, plant and
equipment, net
|
|
|
97,606
|
|
|
|
98,510
|
|
|
|
99,626
|
|
|
(0.9) %
|
|
(2.0) %
|
Right of use
assets
|
|
|
56,650
|
|
|
|
55,689
|
|
|
|
53,842
|
|
|
1.7 %
|
|
5.2 %
|
Intangibles, goodwill
and other long-term assets, net
|
|
|
210,983
|
|
|
|
210,072
|
|
|
|
209,791
|
|
|
0.4 %
|
|
0.6 %
|
Total assets
|
|
$
|
600,466
|
|
|
$
|
597,799
|
|
|
$
|
586,395
|
|
|
0.4 %
|
|
2.4 %
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND
EQUITY:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accounts
payable
|
|
$
|
33,627
|
|
|
$
|
36,863
|
|
|
$
|
33,506
|
|
|
(8.8) %
|
|
0.4 %
|
Short-term operating
lease liabilities
|
|
|
11,435
|
|
|
|
11,045
|
|
|
|
10,175
|
|
|
3.5 %
|
|
12.4 %
|
Other current
liabilities
|
|
|
49,876
|
|
|
|
49,690
|
|
|
|
44,416
|
|
|
0.4 %
|
|
12.3 %
|
Total current
liabilities
|
|
|
94,938
|
|
|
|
97,598
|
|
|
|
88,097
|
|
|
(2.7) %
|
|
7.8 %
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Long-term debt,
net
|
|
|
139,872
|
|
|
|
147,621
|
|
|
|
163,134
|
|
|
(5.2) %
|
|
(14.3) %
|
Long-term operating
lease liabilities
|
|
|
43,727
|
|
|
|
42,616
|
|
|
|
42,076
|
|
|
2.6 %
|
|
3.9 %
|
Other long-term
liabilities
|
|
|
65,508
|
|
|
|
64,270
|
|
|
|
63,281
|
|
|
1.9 %
|
|
3.5 %
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total equity
|
|
|
256,421
|
|
|
|
245,694
|
|
|
|
229,807
|
|
|
4.4 %
|
|
11.6 %
|
Total liabilities and
equity
|
|
$
|
600,466
|
|
|
$
|
597,799
|
|
|
$
|
586,395
|
|
|
0.4 %
|
|
2.4 %
|
CORE LABORATORIES
INC. & SUBSIDIARIES
CONDENSED
CONSOLIDATED STATEMENTS OF CASH FLOWS
(In
thousands)
(Unaudited)
|
|
|
|
|
Nine Months Ended
September 30,
|
|
|
|
2024
|
|
|
2023
|
|
CASH FLOWS FROM
OPERATING ACTIVITIES:
|
|
|
|
|
|
|
Net income
|
|
$
|
24,684
|
|
|
$
|
34,591
|
|
Adjustments to
reconcile net income to net cash provided by operating
activities:
|
|
|
|
|
|
|
Stock-based
compensation
|
|
|
4,213
|
|
|
|
12,406
|
|
Depreciation and
amortization
|
|
|
11,289
|
|
|
|
11,910
|
|
Deferred income
taxes
|
|
|
102
|
|
|
|
(14,757)
|
|
Accounts
receivable
|
|
|
(9,461)
|
|
|
|
2,872
|
|
Inventories
|
|
|
6,212
|
|
|
|
(14,614)
|
|
Accounts
payable
|
|
|
(373)
|
|
|
|
(13,101)
|
|
Other adjustments to
net income
|
|
|
(893)
|
|
|
|
(13,947)
|
|
Net cash provided
by operating activities
|
|
|
35,773
|
|
|
|
5,360
|
|
|
|
|
|
|
|
|
CASH FLOWS FROM
INVESTING ACTIVITIES:
|
|
|
|
|
|
|
Capital
expenditures
|
|
|
(8,647)
|
|
|
|
(7,843)
|
|
Net proceeds on life
insurance policies and from insurance recovery
|
|
|
4,878
|
|
|
|
3,375
|
|
Other investing
activities
|
|
|
934
|
|
|
|
262
|
|
Net cash used in
investing activities
|
|
|
(2,835)
|
|
|
|
(4,206)
|
|
|
|
|
|
|
|
|
CASH FLOWS FROM
FINANCING ACTIVITIES:
|
|
|
|
|
|
|
Repayment of long-term
debt
|
|
|
(62,000)
|
|
|
|
(184,000)
|
|
Proceeds from long-term
debt
|
|
|
38,000
|
|
|
|
190,000
|
|
Debt issuance
cost
|
|
|
—
|
|
|
|
(1,251)
|
|
Dividends
paid
|
|
|
(1,407)
|
|
|
|
(1,401)
|
|
Repurchase of common
shares
|
|
|
(402)
|
|
|
|
(418)
|
|
Equity related
transaction costs
|
|
|
(756)
|
|
|
|
(2,842)
|
|
Other financing
activities
|
|
|
(19)
|
|
|
|
(54)
|
|
Net cash provided
by (used in) financing activities
|
|
|
(26,584)
|
|
|
|
34
|
|
|
|
|
|
|
|
|
NET CHANGE IN CASH AND
CASH EQUIVALENTS
|
|
|
6,354
|
|
|
|
1,188
|
|
CASH AND CASH
EQUIVALENTS, beginning of period
|
|
|
15,120
|
|
|
|
15,428
|
|
CASH AND CASH
EQUIVALENTS, end of period
|
|
$
|
21,474
|
|
|
$
|
16,616
|
|
Non-GAAP Information
Management believes that the exclusion of certain income and
expenses enables it to evaluate more effectively the Company's
operations period-over-period and to identify operating trends that
could otherwise be masked by the excluded Items. For this reason,
management uses certain non-GAAP measures that exclude these Items
and believes that this presentation provides a clearer comparison
with the results reported in prior periods. The non-GAAP financial
measures should be considered in addition to, and not as a
substitute for, the financial results prepared in accordance with
GAAP, as more fully discussed in the Company's financial statements
and filings with the Securities and Exchange Commission.
Reconciliation of
Operating Income, Net Income and Diluted Earnings Per Share
Attributable to Core Laboratories Inc.
(In thousands, except
per share data)
(Unaudited)
|
|
|
|
Operating
Income
|
|
|
|
Three Months
Ended
|
|
|
|
September 30,
2024
|
|
|
June 30,
2024
|
|
|
September 30,
2023
|
|
GAAP
reported
|
|
$
|
19,803
|
|
|
$
|
16,008
|
|
|
$
|
14,672
|
|
Stock compensation
(1)
|
|
|
(1,364)
|
|
|
|
—
|
|
|
|
—
|
|
Loss on lease
abandonment and assets write-down (2)
|
|
|
—
|
|
|
|
—
|
|
|
|
633
|
|
ATM termination costs
(3)
|
|
|
—
|
|
|
|
—
|
|
|
|
455
|
|
Foreign exchange losses
(gains)
|
|
|
(239)
|
|
|
|
388
|
|
|
|
238
|
|
Excluding specific
items
|
|
$
|
18,200
|
|
|
$
|
16,396
|
|
|
$
|
15,998
|
|
|
|
|
|
Net Income
Attributable to Core Laboratories Inc.
|
|
|
|
Three Months
Ended
|
|
|
|
September 30,
2024
|
|
|
June 30,
2024
|
|
|
September 30,
2023
|
|
GAAP
reported
|
|
$
|
11,745
|
|
|
$
|
9,032
|
|
|
$
|
9,257
|
|
Stock compensation
(1)
|
|
|
(1,091)
|
|
|
|
—
|
|
|
|
—
|
|
Loss on lease
abandonment and assets write-down (2)
|
|
|
—
|
|
|
|
—
|
|
|
|
505
|
|
ATM termination costs
(3)
|
|
|
—
|
|
|
|
—
|
|
|
|
364
|
|
Foreign exchange losses
(gains)
|
|
|
(191)
|
|
|
|
310
|
|
|
|
190
|
|
Effect of higher
(lower) tax rate (4)
|
|
|
1,351
|
|
|
|
1,050
|
|
|
|
—
|
|
Excluding specific
items
|
|
$
|
11,814
|
|
|
$
|
10,392
|
|
|
$
|
10,316
|
|
|
|
|
|
Diluted Earnings Per
Share Attributable to Core Laboratories Inc.
|
|
|
|
Three Months
Ended
|
|
|
|
September 30,
2024
|
|
|
June 30,
2024
|
|
|
September 30,
2023
|
|
GAAP
reported
|
|
$
|
0.25
|
|
|
$
|
0.19
|
|
|
$
|
0.19
|
|
Stock compensation
(1)
|
|
|
(0.02)
|
|
|
|
—
|
|
|
|
—
|
|
Loss on lease
abandonment and assets write-down (2)
|
|
|
—
|
|
|
|
—
|
|
|
|
0.01
|
|
ATM termination costs
(3)
|
|
|
—
|
|
|
|
—
|
|
|
|
0.01
|
|
Foreign exchange losses
(gains)
|
|
|
(0.01)
|
|
|
|
0.01
|
|
|
|
0.01
|
|
Effect of higher
(lower) tax rate (4)
|
|
|
0.03
|
|
|
|
0.02
|
|
|
|
—
|
|
Excluding specific
items
|
|
$
|
0.25
|
|
|
$
|
0.22
|
|
|
$
|
0.22
|
|
|
|
|
|
|
|
|
|
|
|
(1) Three months ended September 30, 2024 includes
reversals of stock compensation expense previously recognized due
to a change in probability of performance condition for certain
executive's share awards.
|
(2) Three months ended September 30, 2023 includes
the write-down of leasehold improvements, right of use assets
and/or other assets and exit costs associated with consolidation of
certain facilities.
|
(3) Three months ended September 30, 2023 includes
the write off of previously deferred costs upon termination of our
"at-the-market offering" ("ATM") Program.
|
(4) Three months ended September 30, 2024 and June
30, 2024 includes the effect to reflect tax expense at a normalized
rate of 20%.
|
Segment
Information
(In
thousands)
(Unaudited)
|
|
|
|
Operating
Income
|
|
|
|
Three Months Ended
September 30, 2024
|
|
|
|
Reservoir
Description
|
|
|
Production
Enhancement
|
|
|
Corporate and
Other
|
|
GAAP
reported
|
|
$
|
16,487
|
|
|
$
|
3,232
|
|
|
$
|
84
|
|
Stock
compensation
|
|
|
(881)
|
|
|
|
(483)
|
|
|
|
—
|
|
Foreign exchange losses
(gains)
|
|
|
(157)
|
|
|
|
(117)
|
|
|
|
35
|
|
Excluding specific
items
|
|
$
|
15,449
|
|
|
$
|
2,632
|
|
|
$
|
119
|
|
Return on Invested Capital
Return on Invested Capital ("ROIC") is presented based on
management's belief that this non-GAAP measure is useful
information to investors and management when comparing
profitability and the efficiency with which capital has been
employed over time relative to other companies. The Board has
established an internal metric to demonstrate ROIC performance
relative to the oilfield service companies listed as Core's Comp
Group by Bloomberg. ROIC is not a measure of financial performance
under GAAP and should not be considered as an alternative to net
income.
ROIC of 8.6% is defined by Bloomberg as Net Operating Profit
After Tax ("NOPAT") of $34.9 million
divided by Average Total Invested Capital ("Average TIC") of
$407.6 million where, NOPAT is
defined as GAAP net income before non-controlling interest
plus the sum of income tax expense, interest expense, and
pension expense less pension service cost and tax effect on
income before interest and tax expense for the last four quarters.
Average TIC is defined as the average of beginning and ending
periods' GAAP stockholders' equity plus the sum of net
long-term debt, lease liabilities, allowance for credit losses, net
of deferred taxes, and income taxes payable.
Free Cash Flow
Core uses the non-GAAP financial measure of free cash flow to
evaluate its cash flows and results of operations. Free cash flow
is defined as net cash provided by operating activities (which is
the most directly comparable GAAP measure) less cash paid for
capital expenditures. Management believes that free cash flow
provides useful information to investors regarding the cash
available in the period that was in excess of Core's needs to fund
its capital expenditures and operating activities. Free cash flow
is not a measure of operating performance under GAAP and should not
be considered in isolation nor construed as an alternative to
operating income, net income, or cash flows from operating,
investing, or financing activities, each as determined in
accordance with GAAP. Free cash does not represent residual cash
available for distribution because Core may have other
non-discretionary expenditures that are not deducted from the
measure. Moreover, since free cash flow is not a measure determined
in accordance with GAAP and thus is susceptible to varying
interpretations and calculations, free cash flow as presented may
not be comparable to similarly titled measures presented by other
companies.
Computation of Free
Cash Flow
(In
thousands)
(Unaudited)
|
|
|
|
Three Months
Ended
|
|
|
Nine Months
Ended
|
|
|
|
|
September 30,
2024
|
|
|
September 30,
2024
|
|
|
Net cash provided by
operating activities
|
|
$
|
13,097
|
|
|
$
|
35,773
|
|
|
Capital
expenditures
|
|
|
(2,729)
|
|
|
|
(8,647)
|
|
|
Free cash
flow
|
|
$
|
10,368
|
|
|
$
|
27,126
|
|
|
View original content to download
multimedia:https://www.prnewswire.com/news-releases/core-lab-reports-third-quarter-2024-results-302285122.html
SOURCE Core Laboratories Inc